Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Packaging Corp Of America (PKG): Insiders Aren’t Crazy About It But Hedge Funds Love It

Page 1 of 2

In today’s marketplace, there are tons of metrics investors can use to track the equity markets. A couple of the best are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best hedge fund managers can trounce the S&P 500 by a significant margin (see just how much).

 Packaging Corp Of America (NYSE:PKG)

Equally as key, positive insider trading sentiment is another way to look at the stock market universe. As the old adage goes: there are many reasons for an executive to sell shares of his or her company, but just one, very simple reason why they would buy. Various empirical studies have demonstrated the valuable potential of this strategy if piggybackers know what to do (learn more here).

Furthermore, let’s study the recent info for Packaging Corp Of America (NYSE:PKG).

Hedge fund activity in Packaging Corp Of America (NYSE:PKG)

In preparation for the third quarter, a total of 25 of the hedge funds we track held long positions in this stock, a change of 14% from one quarter earlier. With the smart money’s capital changing hands, there exists a few key hedge fund managers who were increasing their stakes significantly.

Out of the hedge funds we follow, Matt McLennan’s First Eagle Investment Management had the biggest position in Packaging Corp Of America (NYSE:PKG), worth close to $67.9 million, accounting for 0.2% of its total 13F portfolio. Sitting at the No. 2 spot is Robert B. Gillam of McKinley Capital Management, with a $31.3 million position; the fund has 1.6% of its 13F portfolio invested in the stock. Other peers with similar optimism include D. E. Shaw’s D E Shaw, SAC Subsidiary’s CR Intrinsic Investors and Andrew Sandler’s Sandler Capital Management.

As one would understandably expect, specific money managers have jumped into Packaging Corp Of America (NYSE:PKG) headfirst. First Eagle Investment Management, managed by Matt McLennan, initiated the biggest position in Packaging Corp Of America (NYSE:PKG). First Eagle Investment Management had 67.9 million invested in the company at the end of the quarter. Robert B. Gillam’s McKinley Capital Management also made a $31.3 million investment in the stock during the quarter. The other funds with brand new PKG positions are D. E. Shaw’s D E Shaw, SAC Subsidiary’s CR Intrinsic Investors, and Andrew Sandler’s Sandler Capital Management.

What have insiders been doing with Packaging Corp Of America (NYSE:PKG)?

Insider buying made by high-level executives is most useful when the company in question has seen transactions within the past 180 days. Over the latest six-month time period, Packaging Corp Of America (NYSE:PKG) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll check out the relationship between both of these indicators in other stocks similar to Packaging Corp Of America (NYSE:PKG). These stocks are AptarGroup, Inc. (NYSE:ATR), Sealed Air Corp (NYSE:SEE), Bemis Company, Inc. (NYSE:BMS), Owens-Illinois Inc (NYSE:OI), and Tupperware Brands Corporation (NYSE:TUP). This group of stocks are the members of the packaging & containers industry and their market caps are similar to PKG’s market cap.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!